We’re Proud to Announce Our PLOS One Publication: Evaluating OpenBioLLM’s Diagnostic Performance in Neurology

We are delighted to announce the publication of our latest research article, “Evaluating the diagnostic performance of OpenBioLLM in neurology: A case-based assessment of a medical large language model”, in the internationally recognized PLOS One journal (Impact Factor: 2.6, Q1 in Multidisciplinary Science).

Why is this article significant?

Artificial intelligence continues to reshape clinical decision-making, yet its real-world diagnostic accuracy remains under scrutiny. This study evaluates how a specialized medical large language model, OpenBioLLM, performs in diagnosing complex neurology cases — one of the most cognitively demanding areas in medicine.

What does the article reveal?

• The findings demonstrate that OpenBioLLM shows:
• Strong reasoning ability and fluency in clinical dialogue
• Promising capacity in lesion localization
• Moderate accuracy in identifying underlying neurological causes, suggesting the need for integration with retrieval-based or hybrid models for enhanced diagnostic precision

These results highlight both the potential and current limitations of large language models in clinical neurology and pave the way for developing next-generation AI systems that combine reasoning with medical knowledge retrieval.

Toward the Future of AI-Enhanced Medicine

This publication represents another milestone in the ongoing mission of Novarea and its official representative, Hekma Smart Solutions, to advance AI in healthcare.

Our interdisciplinary team is currently working on adapting and improving such models through innovative frameworks like Retrieval-Augmented Generation (RAG) to enhance real-time diagnostic support and medical reasoning.

Collaborative Innovation Across Borders

This research effort reflects the collaborative vision of Novarea (Novarea AI) and its official representative, Hekma Smart Solutions (Oman), in building global partnerships that bridge academic research, clinical expertise, and AI innovation.

Together, we continue to pioneer projects that integrate medical intelligence, data ethics, and localized health technologies to empower the next generation of healthcare solutions.

Our Research Article Published in Digital Health Journal: Next Generation of Language Models and Synthetic Approaches in Medical AI

We are proud to announce the publication of our new research in the internationally renowned Digital Health journal. This study addresses one of the most advanced approaches in medical artificial intelligence, Retrieval-Augmented Generation (RAG).

Why is this article significant?

Despite the impressive capabilities of large language models like GPT in generating text, they face limitations in the novelty of information and the accuracy of scientific content. This study demonstrates that integrating external search modules with these models can significantly enhance the quality of responses in medical applications.

What does the article review?

The article provides a narrative review of research that utilized RAG technology to improve AI performance in the medical field. Key advantages of this approach include:  

  • Simultaneous access to the model’s memory and online medical information sources  
  • Reduction of model-generated hallucinations  
  • Enhanced accuracy and realism in responses to clinical questions and decision-making  

Beyond the Review: A Roadmap for Future Research

The article not only reviews existing research but also identifies research gaps and proposes avenues for designing more precise evaluation frameworks in future projects, including: 

  • The need for rigorous comparative testing  
  • Development of standardized sources for information extraction  
  • Deeper understanding of user interaction with systems  

Hekma Leads in Integrating Language Models with Localized RAG Systems.

Our AI team is currently working on developing healthcare AI systems based on this framework, such as symptom-diagnosing chat bots, health education tools, and medical decision-support systems. This article serves as a scientific document for one of these emerging projects.

Toward a Smarter Future in Digital Health

Pur AI team, comprising over 100 specialists in medical and technical fields, is working on designing the next generation of AI tools to transform the healthcare system, from specialized chat bots and deep learning platforms to disease prediction models and smart patient management systems.

In addition to publishing in prestigious scientific journals, Hekma adopts a pioneering approach to commercializing its innovative products and has established extensive partnerships with Canadian based Novarea Inc. and also universities, research centers, practicing physicians, and local and international business incubators.

Strategic Partnership between Hekma Smart Solutions (Oman) and DigiMedica (Australia)

Hekma Smart Solutions is proud to announce the signing of a Memorandum of Understanding (MoU) with DigiMedica Pty Ltd, a healthtech company based in Australia. This collaboration marks a significant step toward cooperation of these two companies at the intersection of Artificial Intelligence (AI) and Digital Health.

The agreement outlines a wide range of joint activities across research, education, product development, commercialization, and strategic consulting.

Key Areas of Collaboration:

  • Research & Development in AI-powered healthcare projects
  • Design and development of joint digital health products
  • Educational programs including webinars, workshops, and training sessions
  • Consulting services for healthcare organizations in AI and digital health
  • Market expansion across the Gulf region and Australian markets
  • Joint development of an AI-based diabetes management platform

Dr Gholamreza Habibi, CEO of Hekma, stated:

“With our regional expertise and DigiMedica’s specialized capabilities in AI-driven health innovation in Australia, this partnership empowers us to co-create intelligent healthcare solutions that are scalable and impactful.”

DigiMedica Pty Ltd is an Australian health-tech company focused on advancing digital health and AI-driven healthcare innovations, delivering impactful solutions within the Australian market.

Hekma Smart Solutions is an Omani company specializing in innovative AI and digital health solutions, dedicated to addressing regional healthcare challenges with cutting-edge technology. Hekma is exclusive representative of Canadian based company – NOVAREA Inc.

For further information about the partnership and opportunities for collaboration, please reach out to Hekma’s Public Relations team.

Novarea Inc. (Canadian firm) and Hekma Smart Solutions (Omani firm) Forge Strategic Partnership to Boost Healthcare and Tech Innovation

Novarea Inc., a leading Canadian company specializing in AI and health technology, has signed a groundbreaking cooperation agreement with Oman’s Hekma Smart Solutions to enhance research, technology transfer, and AI-driven healthcare services in the Gulf Cooperation Council (GCC) region.

A Vision for Growth and Innovation

“This partnership marks a significant step in strengthening ties between Oman and Canada in healthcare and technology,” said Dr Gholamreza Habibi, CEO of Hekma Smart Solutions. “By combining our expertise with Hekma’s regional insights, we aim to drive innovation and improve healthcare outcomes in the GCC.” He added, “This collaboration aligns with Oman’s vision for a knowledge-based economy. We are excited to bring Novarea’s cutting-edge solutions to the region and empower local institutions with advanced research and AI capabilities.”

The agreement sets the stage for long-term cooperation, positioning both companies as key players in the GCC’s evolving healthcare and technology landscape.

Key Areas of Cooperation

1. Clinical Research: Bridging Canada and the GCC

Novarea will facilitate clinical research collaborations between North American pharmaceutical companies, clinical research organizations (CROs), and Omani/GCC institutions. This initiative aims to expand clinical trial opportunities, foster knowledge exchange, and support drug development in the region.

2. Technology Transfer & Tech Product Marketing

Novarea will identify and introduce innovative tech products and companies to Oman and the broader GCC market, enabling technology transfer and commercialization of cutting-edge solutions.

3. Artificial Intelligence (AI) Services

Hekma Smart Solutions will act as Novarea’s official representative in AI, offering advanced services in:

  • Large Language Models (LLM)– AI-driven text analysis, chatbots, and content generation.
  • Image Processing– Medical imaging, object detection, and computer vision.
  • Speech Processing– Voice recognition, natural language processing (NLP), and AI-based transcription.
  • Predictive Analytics– Data modeling and decision-making support.
  • Robotic Process Automation (RPA)– Streamlining business operations with AI.

4. Digital Health Solutions

Leveraging Novarea’s expertise in digital health, the partnership will introduce advanced platforms, including:

  • Telemedicine & Online Consultations
  • Medical Evaluation & Smart Feedback Systems
  • Health Social Networks & Learning Management Systems (LMS)
  • Health Business Intelligence (BI) & Analytics
    Hekma will work with Omani academic medical centers to deploy these solutions.

5. Research Services for Academia

Under the license of Novarea – SciPath Canada, Hekma will offer specialized research services to Omani and GCC universities, research centers, and faculty members, supporting academic and clinical studies.

6. Management & Business Consultation

The two companies will collaborate on providing expert consultancy in:

  • Investment & Financing
  • Market & Product Development
  • Human Resource Strategies
  • Sustainable & Green Corporate Development